(Q48097076)

8 February 2018

title

The effects of amperozide on cocaine-induced social withdrawal in rats. (English)

1 reference

8 February 2018

author name string

Rademacher DJ

1

1 reference

8 February 2018

Kuppinger HE

2

1 reference

8 February 2018

Thompson KJ

3

1 reference

8 February 2018

Harrington A

4

1 reference

8 February 2018

Kaczmarek HJ

5

1 reference

8 February 2018

Kopish AJ

6

1 reference

8 February 2018

Steinpreis RE

7

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

8 February 2018

Behavioural Brain Research

published in

1 reference

8 February 2018

volume

99

1 reference

8 February 2018

issue

1

1 reference

8 February 2018

page(s)

75-80

1 reference

8 February 2018

Amperozide--effect on prolactin release in the rat.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Effects of amperozide on biting behavior and performance in restricted-fed pigs following regrouping

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

A comparison of self-reported symptoms and DSM-III-R criteria for cocaine withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Amperozide: a new pharmacological approach in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Acute and chronic effects of cocaine on isolation-induced aggression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

The effect of amperozide on uptake and release of [3H]-dopamine in vitro from perfused rat striatal and limbic brain areas

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Amperozide and emotional behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Cocaine increases isolation-induced fighting in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Effects of amperozide on psychostimulant-induced hyperlocomotion and dopamine release in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Wasting pig syndrome (WPS) in weaners--treatment with amperozide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Positive and negative schizophrenic symptoms and the role of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Comparison of the action of the 5-HT2 antagonists amperozide and trazodone on preference for alcohol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Volitional consumption of ethanol by fawn-hooded rats: effects of alternative solutions and drug treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Intruder-evoked aggression in isolated and nonisolated mice: Effects of psychomotor stimulants and l-Dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist amperozide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Effect of amperozide on the synthesis and turnover of monoamines in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Cocaine abuse and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2898%2900074-6

7 January 2021

10.1016/S0166-4328(98)00074-6

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

10512574

1 reference

8 February 2018